UCL Discovery Stage
UCL home » Library Services » Electronic resources » UCL Discovery Stage

Soft Tissue Substitutes at Immediate Postextractive Implants to Reduce Tissue Shrinkage – 3-year Results From a Randomized Controlled Trial

Azaripour, A; Buti, J; Sagheb, K; Stock, L; Al Naeas, B; Esposito, M; (2021) Soft Tissue Substitutes at Immediate Postextractive Implants to Reduce Tissue Shrinkage – 3-year Results From a Randomized Controlled Trial. Clinical Trials in Dentistry , 03 (03) , Article 47. 10.36130/ctd.03.2021.04. Green open access

[thumbnail of Azaripour_2021;03(3)47-57.pdf]
Preview
Text
Azaripour_2021;03(3)47-57.pdf - Accepted Version

Download (889kB) | Preview

Abstract

PURPOSE. The aim of this parallel randomized controlled trial (RCT) was to evaluate whether placement of a soft tissue graft substitute (STGS) could decrease peri-implant tissue shrinkage at immediate post-extractive implants. MATERIALS AND METHODS. Twenty patients with one missing tooth between two adja-cent healthy teeth in aesthetic areas and at least 4 mm of bone apically to the tooth apex were randomly allocated after tooth extraction to receive or not a subepithelial buccal STGS. Implants were inserted with a torque of at least 30 Ncm and sites were grafted with a cancellous particulate allograft. Ten patients received a buccal STGS and 10 patients did not (control group). All patients were restored with non-occluding immediate provisional screw-retained crowns, replaced after 6 months by definitive metal-ceramic crowns, and were followed to 3-year after grafting/loading. RESULTS. Three-year after loading, no drop-out, crown or implant failure or complication occurred. No statistically significant difference or trends in aesthetics (difference = 0.2, 95% CI:-0.81 to 1.21; P = 0.97), peri-implant marginal bone loss (difference = 0.14 mm; 95% CI:-0.27 to 0.57; P = 0.58) and keratinized mucosa heights (difference = 0.8 mm; 95% CI:-1.79 to 3.39; P = 0.57) between the two groups were observed. CONCLUSIONS. Acknowledging that the sample size was small, no clinical benefits could be observed using a soft tissue graft substitute at immediate post-extractive implants up to 3-year after grafting. CONFLICT OF INTEREST STATEMENT. The manufacturer (BEGO Implant Systems, Bremen, Germany) of the implants used in this investigation, partially supported this trial, however data belonged to the authors and by no means the sponsor interfered with the conduct of the trial or the publication of its results.

Type: Article
Title: Soft Tissue Substitutes at Immediate Postextractive Implants to Reduce Tissue Shrinkage – 3-year Results From a Randomized Controlled Trial
Open access status: An open access version is available from UCL Discovery
DOI: 10.36130/ctd.03.2021.04
Publisher version: http://dx.doi.org/10.36130/CTD.03.2021.04
Language: English
Additional information: This version is the version of record. For information on re-use, please refer to the publisher’s terms and conditions.
UCL classification: UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Eastman Dental Institute > Restorative Dental Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Eastman Dental Institute
URI: https://discovery-pp.ucl.ac.uk/id/eprint/10157486
Downloads since deposit
7,752Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item